Boston Scientific Corp. vs. Haemonetics Corporation
Boston Scientific Corp. (BSX) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| BSX | HAE | |
|---|---|---|
| Market Cap | $66.68 billion | $5.39 billion |
BSX leads on 1 of 1 size & scale factors.
Risk & Sentiment
| BSX | HAE | |
|---|---|---|
| Short Interest | 0.72% | 1.81% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, HAE overview, HAE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.